Processa Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PCSA and other ETFs, options, and stocks.About PCSA
Processa Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drug products for the treatment of serious medical conditions. Its main product candidate is PCS499, which is intended for the treatment of Necrobiosis Lipoidica.
CEOGeorge K. Ng
CEOGeorge K. Ng
Employees10
Employees10
HeadquartersVero Beach, Florida
HeadquartersVero Beach, Florida
Founded2011
Founded2011
Employees10
Employees10
PCSA Key Statistics
Market cap15.86M
Market cap15.86M
Price-Earnings ratio-0.20
Price-Earnings ratio-0.20
Dividend yield—
Dividend yield—
Average volume917.12K
Average volume917.12K
High today$0.2891
High today$0.2891
Low today$0.2653
Low today$0.2653
Open price$0.2748
Open price$0.2748
Volume732.49K
Volume732.49K
52 Week high$1.50
52 Week high$1.50
52 Week low$0.15
52 Week low$0.15
Stock Snapshot
The current Processa Pharmaceuticals(PCSA) stock price is $0.28, with a market capitalization of 15.86M. The stock trades at a price-to-earnings (P/E) ratio of -0.20.
As of 2025-12-08, Processa Pharmaceuticals(PCSA) stock has fluctuated between $0.27 and $0.29. The current price stands at $0.28, placing the stock +4.9% above today's low and -3.7% off the high.
Processa Pharmaceuticals(PCSA) shares are trading with a volume of 732.49K, against a daily average of 917.12K.
During the past year, Processa Pharmaceuticals(PCSA) stock moved between $0.15 at its lowest and $1.50 at its peak.
During the past year, Processa Pharmaceuticals(PCSA) stock moved between $0.15 at its lowest and $1.50 at its peak.
People also own
Based on the portfolios of people who own PCSA. This list is generated using Robinhood data, and it’s not a recommendation.